AUPH

Aurinia Pharmaceuticals Inc.

Healthcare›Biotechnology|NASDAQ Global Market|CA

Price

$15.61

Market Cap

$2.08B

Beta

1.59

P/E

7.6

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+20.38%

EPS Growth (YoY)+500.00%

Revenue CAGR 3Y+28.30%

P/E Ratio7.6

PEG Ratio0.02

FCF Yield+6.47%

Debt / Equity0.13

Interest Coverage12.1x

No credit card required

Already have an account? Sign in to view the full analysis for AUPH.